SLI Medical Acceptable Dating: we will ship >= 180 days
Storage Requirements
Requires Refrigeration
Strength
60 mg / mL
Type
Intravenous
UNSPSC Code
42142619
Volume
10 mL
Features
SKYRIZI® is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
SKYRIZI is indicated for the treatment of active psoriatic arthritis in adults
SKYRIZI is indicated for the treatment of moderately to severely active Crohn's disease in adults
600 mg/10 mL (60 mg/mL) single-dose vial